Please login to the form below

Not currently logged in
Email:
Password:

ADA 2013

This page shows the latest ADA 2013 news and features for those working in and with pharma, biotech and healthcare.

ADA: Boehringer/ Lilly's empagliflozin shows blood glucose benefits

ADA: Boehringer/ Lilly's empagliflozin shows blood glucose benefits

When taken together, the trials, which were presented over the weekend at the American Diabetes Association's (ADA) Scientific Sessions in Chicago, showed “a very consistent efficacy profile of the drug ... in full at next year's ADA meeting.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics